640. Randomized Clinical Trial Evaluating Clinical Impact of RAPid IDentification and Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia (RAPIDS-GN)
Ritu Banerjee(Vanderbilt University Medical Center), Jennifer Curello(University of California, Los Angeles), Nicolynn C. Cole(Mayo Clinic), Sherry M. Ihde(Mayo Clinic), Abinash Virk(Mayo Clinic in Florida), Lisa B. Hines(Mayo Clinic), Rubi Arias(University of California, Los Angeles), Michelle Earley(George Washington University), Meganne Kanatani(University of California, Los Angeles), Brenda L. Dylla(Mayo Clinic in Arizona), Robin Patel(Mayo Clinic in Arizona), Katelyn A. Reed(Mayo Clinic), Peggy C. Kohner(Mayo Clinic), Annabelle M de St. Maurice(University of California, Los Angeles), Nipunie Rajapakse(Mayo Clinic in Florida), Sukantha Chandrasekaran(University of California, Los Angeles), Omai B. Garner(University of California, Los Angeles), Sarah B. Doernberg(Johns Hopkins University), Audrey N. Schuetz(Mayo Clinic), Judith J. Lok(Boston University), William Swearingen(University of California, Los Angeles), Lauren Komarow(George Washington University)
Cited by 1
Related Papers
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
|Clinical Infectious Diseases|2016|3k
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya
|Clinical Infectious Diseases|2018|618
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)a
|Clinical Infectious Diseases|2013|591